ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,311.26
0.06%
Dow Jones
39,823.51
0.04%
US Dollar vs MXN
16.59993
0.27%
Brent Oil
82.255
-1.53%
Bitcoin
69,938.92
-2.11%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aerpio Pharmaceuticals Inc (ARPO)

  7. Aerpio Pharmaceuticals Inc (ARPO) Noticias

ARPO

Aerpio Pharmaceuticals (ARPO)

Aerpio Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARPO
FechaHoraFuenteTítuloSímboloCompañía
21/06/202305:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
16/06/202314:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202312:25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202311:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/04/202311:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202315:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202315:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202305:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/03/202315:08Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
14/02/202305:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
09/11/202215:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/11/202205:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/11/202215:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
26/10/202215:50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
11/10/202211:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/10/202215:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARPOAerpio Pharmaceuticals Inc
26/09/202216:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/03/202205:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/09/202116:26Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ARPOAerpio Pharmaceuticals Inc
31/08/202118:53Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
09/07/202106:31TipRanksPenny Stock Aerpio Pharmaceuticals’ Merger With Aadi Makes It A Buy, Says AnalystNASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202106:31Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
17/09/202006:00GlobeNewswire Inc.Aravive Appoints Michael W. Rogers to Board of DirectorsNASDAQ:ARPOAerpio Pharmaceuticals Inc
01/09/202015:30PR Newswire (US)Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-...NASDAQ:ARPOAerpio Pharmaceuticals Inc
27/05/202015:30PR Newswire (US)Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation ...NASDAQ:ARPOAerpio Pharmaceuticals Inc
12/05/202015:30GlobeNewswire Inc.Aerpio Announces Amended Licensing Deal with Gossamer Bio on its Inflammatory Bowel Disease (IBD) Product Candidate GB004 (fo...NASDAQ:ARPOAerpio Pharmaceuticals Inc
17/04/202015:46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
12/03/202016:00GlobeNewswire Inc.Aerpio Pharmaceuticals to Report Year Ended December 31, 2019 Financial Results on Monday, March 16, 2020NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/02/202017:20Business WireAerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Pr...NASDAQ:ARPOAerpio Pharmaceuticals Inc
08/01/202007:43Business WireTopical Ocular Formulation of Aerpio Pharmaceutical’s AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperem...NASDAQ:ARPOAerpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARPO

Su Consulta Reciente

NYSE
CVX
Chevron
NYSE
XOM
Exxon Mobil
CCOM
US30
US 30
FX
EURUSD
Euro vs US Dollar
USOTC
BASFY
BASF (QX)
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
NASDAQ
MSFT
Microsoft
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
NYSE
KO
Coca Cola
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados